NCT01683253View on ClinicalTrials.gov

Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Impulse Control Disorder
Interventions
DRUG

Levodopa/Carbidopa(200mg/50mg)

DRUG

Dopaminergic Agonists

Treated for at least 6 months after diagnosis of Parkinson's Disease.

Trial Locations (5)

Unknown

Sandoz Investigative Site, Anyang

Sandoz Investigative Site, Daegu

Sandoz Investigative Site, Pusan

Sandoz Investigative Site, Seongnam

Sandoz Investigative Site, Seoul

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY